2018-2023 Global Needle-Free Injection Device Consumption Market Report
![](/report_cover/10189/2018-2023-global-needle-free-injection-device-consumption-market-report_en.gif)
The report requires updating with new data and is sent in 48 hours after order is placed.
In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Needle-Free Injection Device market for 2018-2023.
Needle-free Injection Device is a type of medical injecting syringe that uses a high-pressure narrow jet of the injection liquid instead of a hypodermic needle to penetrate the epidermis. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas cartridge, small cylinder, or spring.
Needle-free injection systems are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It was developed to reduce the number of needle stick accidents and associated problems.
Firstly, the technology of needle-free injection device industry is developing and the industry concentration is not high, There are over 30 manufacturers around the world, and the leading companies are Zogenix, Bioject, Glide Pharma, Crossject Medical and Injex Pharma, right now the production is almost dominated by producers in Europe and United States. In United States, a few companies occupy more than 60 percent of domestic needle-free injector market. On the other hand, almost all the high-end products produced by the global leaders, and the producers mainly produce low-end products in China and India. USA and Europe have a long history and unshakable status in this industry, such as Bioject and Akra Dermojet, leading the needle-free injection device industry. As to Japan, many big corporation has come into this area, however, the rate of the business in this area is not high compared to other area because Japanese companies always have many business areas. In Germany, it is Injex Pharma that lead the industry.
Nonetheless, this market is not big because the relatively high price of the needle-free injectors compared to the disposable injectors. Mergers and acquisitions usually happen amony needle-free injection devices producers. For example, Bioject has been purchased by Inovio.
Globally, the global production was 2927 K units in 2015, and it will reach 4587K units in 2021. The global production value was 299.39 million USD in 2015, and it is expected that the value will be 436.3 million USD in 2021, with9.14% annual compound growth.
Over the next five years, LPI(LP Information) projects that Needle-Free Injection Device will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Needle-Free Injection Device market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Research objectives
In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Needle-Free Injection Device market for 2018-2023.
Needle-free Injection Device is a type of medical injecting syringe that uses a high-pressure narrow jet of the injection liquid instead of a hypodermic needle to penetrate the epidermis. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas cartridge, small cylinder, or spring.
Needle-free injection systems are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It was developed to reduce the number of needle stick accidents and associated problems.
Firstly, the technology of needle-free injection device industry is developing and the industry concentration is not high, There are over 30 manufacturers around the world, and the leading companies are Zogenix, Bioject, Glide Pharma, Crossject Medical and Injex Pharma, right now the production is almost dominated by producers in Europe and United States. In United States, a few companies occupy more than 60 percent of domestic needle-free injector market. On the other hand, almost all the high-end products produced by the global leaders, and the producers mainly produce low-end products in China and India. USA and Europe have a long history and unshakable status in this industry, such as Bioject and Akra Dermojet, leading the needle-free injection device industry. As to Japan, many big corporation has come into this area, however, the rate of the business in this area is not high compared to other area because Japanese companies always have many business areas. In Germany, it is Injex Pharma that lead the industry.
Nonetheless, this market is not big because the relatively high price of the needle-free injectors compared to the disposable injectors. Mergers and acquisitions usually happen amony needle-free injection devices producers. For example, Bioject has been purchased by Inovio.
Globally, the global production was 2927 K units in 2015, and it will reach 4587K units in 2021. The global production value was 299.39 million USD in 2015, and it is expected that the value will be 436.3 million USD in 2021, with9.14% annual compound growth.
Over the next five years, LPI(LP Information) projects that Needle-Free Injection Device will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Needle-Free Injection Device market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
- Powder Injections
- Liquid Injections
- Depot or Projectile Injection
- Drug Injection
- Cosmetic Surgery Use
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Spain
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Zogenix
- Inovio
- Glide Pharma
- Akra Dermojet
- Crossject Medical Technology
- Injex Pharma
- Eternity Healthcare
- Antares Pharma
- Valeritas
- Medical International Technologies
- Penjet
- PharmaJet
- National Medical Products
- Activa Brand Products
Research objectives
- To study and analyze the global Needle-Free Injection Device consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
- To understand the structure of Needle-Free Injection Device market by identifying its various subsegments.
- Focuses on the key global Needle-Free Injection Device manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
- To analyze the Needle-Free Injection Device with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the consumption of Needle-Free Injection Device submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Needle-Free Injection Device Consumption 2013-2023
2.1.2 Needle-Free Injection Device Consumption CAGR by Region
2.2 Needle-Free Injection Device Segment by Type
2.2.1 Powder Injections
2.2.2 Liquid Injections
2.2.3 Depot or Projectile Injection
2.3 Needle-Free Injection Device Consumption by Type
2.3.1 Global Needle-Free Injection Device Consumption Market Share by Type (2013-2018)
2.3.2 Global Needle-Free Injection Device Revenue and Market Share by Type (2013-2018)
2.3.3 Global Needle-Free Injection Device Sale Price by Type (2013-2018)
2.4 Needle-Free Injection Device Segment by Application
2.4.1 Drug Injection
2.4.2 Cosmetic Surgery Use
2.4.3 Other
2.5 Needle-Free Injection Device Consumption by Application
2.5.1 Global Needle-Free Injection Device Consumption Market Share by Application (2013-2018)
2.5.2 Global Needle-Free Injection Device Value and Market Share by Application (2013-2018)
2.5.3 Global Needle-Free Injection Device Sale Price by Application (2013-2018)
3 GLOBAL NEEDLE-FREE INJECTION DEVICE BY PLAYERS
3.1 Global Needle-Free Injection Device Sales Market Share by Players
3.1.1 Global Needle-Free Injection Device Sales by Players (2016-2018)
3.1.2 Global Needle-Free Injection Device Sales Market Share by Players (2016-2018)
3.2 Global Needle-Free Injection Device Revenue Market Share by Players
3.2.1 Global Needle-Free Injection Device Revenue by Players (2016-2018)
3.2.2 Global Needle-Free Injection Device Revenue Market Share by Players (2016-2018)
3.3 Global Needle-Free Injection Device Sale Price by Players
3.4 Global Needle-Free Injection Device Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Needle-Free Injection Device Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Needle-Free Injection Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 NEEDLE-FREE INJECTION DEVICE BY REGIONS
4.1 Needle-Free Injection Device by Regions
4.1.1 Global Needle-Free Injection Device Consumption by Regions
4.1.2 Global Needle-Free Injection Device Value by Regions
4.2 Americas Needle-Free Injection Device Consumption Growth
4.3 APAC Needle-Free Injection Device Consumption Growth
4.4 Europe Needle-Free Injection Device Consumption Growth
4.5 Middle East & Africa Needle-Free Injection Device Consumption Growth
5 AMERICAS
5.1 Americas Needle-Free Injection Device Consumption by Countries
5.1.1 Americas Needle-Free Injection Device Consumption by Countries (2013-2018)
5.1.2 Americas Needle-Free Injection Device Value by Countries (2013-2018)
5.2 Americas Needle-Free Injection Device Consumption by Type
5.3 Americas Needle-Free Injection Device Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Needle-Free Injection Device Consumption by Countries
6.1.1 APAC Needle-Free Injection Device Consumption by Countries (2013-2018)
6.1.2 APAC Needle-Free Injection Device Value by Countries (2013-2018)
6.2 APAC Needle-Free Injection Device Consumption by Type
6.3 APAC Needle-Free Injection Device Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 EUROPE
7.1 Europe Needle-Free Injection Device by Countries
7.1.1 Europe Needle-Free Injection Device Consumption by Countries (2013-2018)
7.1.2 Europe Needle-Free Injection Device Value by Countries (2013-2018)
7.2 Europe Needle-Free Injection Device Consumption by Type
7.3 Europe Needle-Free Injection Device Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Needle-Free Injection Device by Countries
8.1.1 Middle East & Africa Needle-Free Injection Device Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Needle-Free Injection Device Value by Countries (2013-2018)
8.2 Middle East & Africa Needle-Free Injection Device Consumption by Type
8.3 Middle East & Africa Needle-Free Injection Device Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 MARKETING, DISTRIBUTORS AND CUSTOMER
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Needle-Free Injection Device Distributors
10.3 Needle-Free Injection Device Customer
11 GLOBAL NEEDLE-FREE INJECTION DEVICE MARKET FORECAST
11.1 Global Needle-Free Injection Device Consumption Forecast (2018-2023)
11.2 Global Needle-Free Injection Device Forecast by Regions
11.2.1 Global Needle-Free Injection Device Forecast by Regions (2018-2023)
11.2.2 Global Needle-Free Injection Device Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Needle-Free Injection Device Forecast by Type
11.8 Global Needle-Free Injection Device Forecast by Application
12 KEY PLAYERS ANALYSIS
12.1 Zogenix
12.1.1 Company Details
12.1.2 Needle-Free Injection Device Product Offered
12.1.3 Zogenix Needle-Free Injection Device Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Zogenix News
12.2 Inovio
12.2.1 Company Details
12.2.2 Needle-Free Injection Device Product Offered
12.2.3 Inovio Needle-Free Injection Device Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Inovio News
12.3 Glide Pharma
12.3.1 Company Details
12.3.2 Needle-Free Injection Device Product Offered
12.3.3 Glide Pharma Needle-Free Injection Device Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Glide Pharma News
12.4 Akra Dermojet
12.4.1 Company Details
12.4.2 Needle-Free Injection Device Product Offered
12.4.3 Akra Dermojet Needle-Free Injection Device Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Akra Dermojet News
12.5 Crossject Medical Technology
12.5.1 Company Details
12.5.2 Needle-Free Injection Device Product Offered
12.5.3 Crossject Medical Technology Needle-Free Injection Device Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Crossject Medical Technology News
12.6 Injex Pharma
12.6.1 Company Details
12.6.2 Needle-Free Injection Device Product Offered
12.6.3 Injex Pharma Needle-Free Injection Device Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Injex Pharma News
12.7 Eternity Healthcare
12.7.1 Company Details
12.7.2 Needle-Free Injection Device Product Offered
12.7.3 Eternity Healthcare Needle-Free Injection Device Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Eternity Healthcare News
12.8 Antares Pharma
12.8.1 Company Details
12.8.2 Needle-Free Injection Device Product Offered
12.8.3 Antares Pharma Needle-Free Injection Device Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Antares Pharma News
12.9 Valeritas
12.9.1 Company Details
12.9.2 Needle-Free Injection Device Product Offered
12.9.3 Valeritas Needle-Free Injection Device Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Valeritas News
12.10 Medical International Technologies
12.10.1 Company Details
12.10.2 Needle-Free Injection Device Product Offered
12.10.3 Medical International Technologies Needle-Free Injection Device Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 Medical International Technologies News
12.11 Penjet
12.12 PharmaJet
12.13 National Medical Products
12.14 Activa Brand Products
13 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Needle-Free Injection Device Consumption 2013-2023
2.1.2 Needle-Free Injection Device Consumption CAGR by Region
2.2 Needle-Free Injection Device Segment by Type
2.2.1 Powder Injections
2.2.2 Liquid Injections
2.2.3 Depot or Projectile Injection
2.3 Needle-Free Injection Device Consumption by Type
2.3.1 Global Needle-Free Injection Device Consumption Market Share by Type (2013-2018)
2.3.2 Global Needle-Free Injection Device Revenue and Market Share by Type (2013-2018)
2.3.3 Global Needle-Free Injection Device Sale Price by Type (2013-2018)
2.4 Needle-Free Injection Device Segment by Application
2.4.1 Drug Injection
2.4.2 Cosmetic Surgery Use
2.4.3 Other
2.5 Needle-Free Injection Device Consumption by Application
2.5.1 Global Needle-Free Injection Device Consumption Market Share by Application (2013-2018)
2.5.2 Global Needle-Free Injection Device Value and Market Share by Application (2013-2018)
2.5.3 Global Needle-Free Injection Device Sale Price by Application (2013-2018)
3 GLOBAL NEEDLE-FREE INJECTION DEVICE BY PLAYERS
3.1 Global Needle-Free Injection Device Sales Market Share by Players
3.1.1 Global Needle-Free Injection Device Sales by Players (2016-2018)
3.1.2 Global Needle-Free Injection Device Sales Market Share by Players (2016-2018)
3.2 Global Needle-Free Injection Device Revenue Market Share by Players
3.2.1 Global Needle-Free Injection Device Revenue by Players (2016-2018)
3.2.2 Global Needle-Free Injection Device Revenue Market Share by Players (2016-2018)
3.3 Global Needle-Free Injection Device Sale Price by Players
3.4 Global Needle-Free Injection Device Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Needle-Free Injection Device Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Needle-Free Injection Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 NEEDLE-FREE INJECTION DEVICE BY REGIONS
4.1 Needle-Free Injection Device by Regions
4.1.1 Global Needle-Free Injection Device Consumption by Regions
4.1.2 Global Needle-Free Injection Device Value by Regions
4.2 Americas Needle-Free Injection Device Consumption Growth
4.3 APAC Needle-Free Injection Device Consumption Growth
4.4 Europe Needle-Free Injection Device Consumption Growth
4.5 Middle East & Africa Needle-Free Injection Device Consumption Growth
5 AMERICAS
5.1 Americas Needle-Free Injection Device Consumption by Countries
5.1.1 Americas Needle-Free Injection Device Consumption by Countries (2013-2018)
5.1.2 Americas Needle-Free Injection Device Value by Countries (2013-2018)
5.2 Americas Needle-Free Injection Device Consumption by Type
5.3 Americas Needle-Free Injection Device Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Needle-Free Injection Device Consumption by Countries
6.1.1 APAC Needle-Free Injection Device Consumption by Countries (2013-2018)
6.1.2 APAC Needle-Free Injection Device Value by Countries (2013-2018)
6.2 APAC Needle-Free Injection Device Consumption by Type
6.3 APAC Needle-Free Injection Device Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 EUROPE
7.1 Europe Needle-Free Injection Device by Countries
7.1.1 Europe Needle-Free Injection Device Consumption by Countries (2013-2018)
7.1.2 Europe Needle-Free Injection Device Value by Countries (2013-2018)
7.2 Europe Needle-Free Injection Device Consumption by Type
7.3 Europe Needle-Free Injection Device Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Needle-Free Injection Device by Countries
8.1.1 Middle East & Africa Needle-Free Injection Device Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Needle-Free Injection Device Value by Countries (2013-2018)
8.2 Middle East & Africa Needle-Free Injection Device Consumption by Type
8.3 Middle East & Africa Needle-Free Injection Device Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 MARKETING, DISTRIBUTORS AND CUSTOMER
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Needle-Free Injection Device Distributors
10.3 Needle-Free Injection Device Customer
11 GLOBAL NEEDLE-FREE INJECTION DEVICE MARKET FORECAST
11.1 Global Needle-Free Injection Device Consumption Forecast (2018-2023)
11.2 Global Needle-Free Injection Device Forecast by Regions
11.2.1 Global Needle-Free Injection Device Forecast by Regions (2018-2023)
11.2.2 Global Needle-Free Injection Device Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Needle-Free Injection Device Forecast by Type
11.8 Global Needle-Free Injection Device Forecast by Application
12 KEY PLAYERS ANALYSIS
12.1 Zogenix
12.1.1 Company Details
12.1.2 Needle-Free Injection Device Product Offered
12.1.3 Zogenix Needle-Free Injection Device Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Zogenix News
12.2 Inovio
12.2.1 Company Details
12.2.2 Needle-Free Injection Device Product Offered
12.2.3 Inovio Needle-Free Injection Device Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Inovio News
12.3 Glide Pharma
12.3.1 Company Details
12.3.2 Needle-Free Injection Device Product Offered
12.3.3 Glide Pharma Needle-Free Injection Device Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Glide Pharma News
12.4 Akra Dermojet
12.4.1 Company Details
12.4.2 Needle-Free Injection Device Product Offered
12.4.3 Akra Dermojet Needle-Free Injection Device Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Akra Dermojet News
12.5 Crossject Medical Technology
12.5.1 Company Details
12.5.2 Needle-Free Injection Device Product Offered
12.5.3 Crossject Medical Technology Needle-Free Injection Device Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Crossject Medical Technology News
12.6 Injex Pharma
12.6.1 Company Details
12.6.2 Needle-Free Injection Device Product Offered
12.6.3 Injex Pharma Needle-Free Injection Device Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Injex Pharma News
12.7 Eternity Healthcare
12.7.1 Company Details
12.7.2 Needle-Free Injection Device Product Offered
12.7.3 Eternity Healthcare Needle-Free Injection Device Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Eternity Healthcare News
12.8 Antares Pharma
12.8.1 Company Details
12.8.2 Needle-Free Injection Device Product Offered
12.8.3 Antares Pharma Needle-Free Injection Device Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Antares Pharma News
12.9 Valeritas
12.9.1 Company Details
12.9.2 Needle-Free Injection Device Product Offered
12.9.3 Valeritas Needle-Free Injection Device Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Valeritas News
12.10 Medical International Technologies
12.10.1 Company Details
12.10.2 Needle-Free Injection Device Product Offered
12.10.3 Medical International Technologies Needle-Free Injection Device Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 Medical International Technologies News
12.11 Penjet
12.12 PharmaJet
12.13 National Medical Products
12.14 Activa Brand Products
13 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES AND FIGURES
Figure Picture of Needle-Free Injection Device
Table Product Specifications of Needle-Free Injection Device
Figure Needle-Free Injection Device Report Years Considered
Figure Market Research Meth
Figure Picture of Needle-Free Injection Device
Table Product Specifications of Needle-Free Injection Device
Figure Needle-Free Injection Device Report Years Considered
Figure Market Research Meth